Dienstag, 30. April 2024, 13:00 - 16:30 iCal
AI meets Life Sciences:
Novel Approaches to Healthcare and Drug Development
Online Event
This webinar delves into one of the most crucial and intriguing questions for humanity: How can we accelerate the development of new medications and revolutionise healthcare? For answers, we look into Artificial Intelligence and supercomputing technologies that are enabling entirely new approaches to science and research.
At the webinar, leading professionals in life sciences will guide you through the landscape of AI tools in structural biology with a focus on the groundbreaking AlphaFold, discuss the role of AI for personalised medical therapies and explore the role of supercomputers in this endeavor.
Join us as we unravel answers to some of the most captivating questions in the domain of life sciences and ignite fresh perspectives!
Agenda
--------------------
14:00 - Welcome
14:10 - Artificial Intelligence: A Catalyst for Innovation in Experimental Structural Biology
(Wouter Van Putte - The CEO and Co-Founder of PUXANO, a platform-based company focusing on protein design and structure-guided protein research.)
This overview critically examines the landscape of artificial intelligence tools in structural biology, spanning from the transformative capabilities of AlphaFold2 in predicting protein structures to the emerging potential of diffusion-based protein design methods.
14:35 - Artificial Intelligence for Precision Medicine and Personalized Therapies
(Christoph Bock - Professor of Medical Informatics at the Medical University of Vienna, head of the Institute of Artificial Intelligence in the Department of Medical Data Science, and Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences)
Artificial intelligence (AI) is everywhere – but what does it mean for precision medicine? We use epigenome data and machine learning to infer the developmental history and future potential of single cells, and we work on “programming” cells as biological computers for personalized immune therapy.
15:00 - Advancing Cancer Therapy through Microbiome Profiling
(Barbara Sladek - Established in 2018, Biome Diagnostics GmbH was founded by Barbara Sladek, following her successful completion of a PhD in Biochemistry at the University of Oxford and an MBA at the WU Executive Academy, together with Nikolaus Gasche. In addition to her passion for the gut microbiome, Sladek co-founded an association to empower women in the healthcare and IT sectors (women-in-HealthIT) and regularly teaches at universities.)
Barbara Sladek will offer valuable insights into the gut microbiome, sharing the latest scientific discoveries and shedding light on how the company utilizes data to decode its secrets. The human intestinal microbiome consists of a dynamic multispecies community of trillions of bacteria. Identifying the multitude of pathways in which the symbiotic microbiome interacts with the human body is hence an exceedingly complex undertaking. Only with the power of AI and advanced bioinformatic algorithms are we able to decipher the secrets of the intestinal microbiome and use these insights for medical purposes.
15:25 - Q&A + open end
Zur Webseite der Veranstaltung
Veranstalter
Um Anmeldung wird gebeten
Kontakt
Eva Gergely
Zentraler Informatikdienst
IT-Support for Research
+436648176485
eva.gergely@univie.ac.at
Erstellt am Dienstag, 16. April 2024, 12:10
Letzte Änderung am Dienstag, 16. April 2024, 13:57